{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T15:17:08Z","timestamp":1793373428056,"version":"4.5.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2017,4,18]],"date-time":"2017-04-18T00:00:00Z","timestamp":1492473600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100008322","name":"CSL Behring","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008322","id-type":"DOI","asserted-by":"publisher"}]},{"name":"EU 7th Framework program"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Intensive Care Med"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1007\/s00134-017-4786-0","type":"journal-article","created":{"date-parts":[[2017,4,18]],"date-time":"2017-04-18T13:23:59Z","timestamp":1492521839000},"page":"1585-1593","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":123,"title":["Immunoglobulin G for patients with necrotising soft tissue infection (INSTINCT): a randomised, blinded, placebo-controlled trial"],"prefix":"10.1007","volume":"43","author":[{"given":"Martin B.","family":"Madsen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter B.","family":"Hjortrup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco B.","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theis","family":"Lange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Norrby-Teglund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ole","family":"Hyldegaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Perner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,4,18]]},"reference":[{"key":"4786_CR1","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jss.2014.05.006","volume":"192","author":"TW Hakkarainen","year":"2014","unstructured":"Hakkarainen TW, Burkette Ikebata N, Bulger E, Evans HL (2014) Moving beyond survival as a measure of success: understanding the patient experience of necrotizing soft-tissue infections. J Surg Res 192:143\u2013149","journal-title":"J Surg Res"},{"key":"4786_CR2","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s13054-016-1210-z","volume":"20","author":"MB Hansen","year":"2016","unstructured":"Hansen MB, Rasmussen LS, Garred P et al (2016) Pentraxin-3 as a marker of disease severity and risk of death in patients with necrotizing soft tissue infections: a nationwide, prospective, observational study. Crit Care 20:40","journal-title":"Crit Care"},{"key":"4786_CR3","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/QCO.0000000000000240","volume":"29","author":"C Eckmann","year":"2016","unstructured":"Eckmann C (2016) The importance of source control in the management of severe skin and soft tissue infections. Curr Opin Infect Dis 29:139\u2013144","journal-title":"Curr Opin Infect Dis"},{"key":"4786_CR4","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1080\/00365540600786499","volume":"38","author":"L Valiquette","year":"2006","unstructured":"Valiquette L, Low DE, Chow R, McGeer AJ (2006) A survey of physician\u2019s attitudes regarding management of severe group A streptococcal infections. Scand J Infect Dis 38:977\u2013982","journal-title":"Scand J Infect Dis"},{"key":"4786_CR5","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1007\/s00134-015-3916-9","volume":"41","author":"N Prost de","year":"2015","unstructured":"de Prost N, Sbidian E, Chosidow O et al (2015) Management of necrotizing soft tissue infections in the intensive care unit: results of an international survey. Intensive Care Med 41:1506\u20131508","journal-title":"Intensive Care Med"},{"key":"4786_CR6","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1172\/JCI116240","volume":"91","author":"S Takei","year":"1993","unstructured":"Takei S, Arora YK, Walker SM (1993) Intravenous immunoglobulin contains specific antibodies inhibitory to activation of T cells by staphylococcal toxin superantigens [see comment]. J Clin Invest 91:602\u2013607","journal-title":"J Clin Invest"},{"key":"4786_CR7","doi-asserted-by":"crossref","first-page":"3057","DOI":"10.4049\/jimmunol.156.8.3057","volume":"156","author":"A Norrby-Teglund","year":"1996","unstructured":"Norrby-Teglund A, Kaul R, DE Low et al (1996) Plasma from patients with severe invasive group A streptococcal infections treated with normal polyspecific IgG inhibits streptococcal superantigen-induced T cell proliferation and cytokine production. J Immunol 156:3057\u20133064","journal-title":"J Immunol"},{"key":"4786_CR8","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1093\/jac\/dkl173","volume":"58","author":"S Sriskandan","year":"2006","unstructured":"Sriskandan S, Ferguson M, Elliot V et al (2006) Human intravenous immunoglobulin for experimental streptococcal toxic shock: bacterial clearance and modulation of inflammation. J Antimicrob Chemother 58:117\u2013124","journal-title":"J Antimicrob Chemother"},{"key":"4786_CR9","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1086\/376630","volume":"37","author":"J Darenberg","year":"2003","unstructured":"Darenberg J, Ihendyane N, Sj\u00f6lin J et al (2003) Intravenous immunoglobulin G therapy in streptococcal toxic shock syndrome: a European randomized, double-blind, placebo-controlled trial. Clin Infect Dis 37:333\u2013340","journal-title":"Clin Infect Dis"},{"key":"4786_CR10","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1086\/515199","volume":"28","author":"R Kaul","year":"1999","unstructured":"Kaul R, McGeer A, Norrby-Teglund A et al (1999) Intravenous immunoglobulin therapy for streptococcal toxic shock syndrome\u2013a comparative observational study. The Canadian Streptococcal Study Group. Clin Infect Dis 28:800\u2013807","journal-title":"Clin Infect Dis"},{"key":"4786_CR11","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1016\/S0012-3692(15)50887-8","volume":"130","author":"S Mehta","year":"2006","unstructured":"Mehta S, McGeer A, Low DE et al (2006) Morbidity and mortality of patients with invasive group A streptococcal infections admitted to the ICU. Chest 130:1679\u20131686","journal-title":"Chest"},{"key":"4786_CR12","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1093\/cid\/ciu449","volume":"59","author":"A Linn\u00e9r","year":"2014","unstructured":"Linn\u00e9r A, Darenberg J, Sj\u00f6lin J et al (2014) Clinical efficacy of polyspecific intravenous immunoglobulin therapy in patients with streptococcal toxic shock syndrome: a comparative observational study. Clin Infect Dis 59:851\u2013857","journal-title":"Clin Infect Dis"},{"key":"4786_CR13","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1093\/cid\/ciu304","volume":"59","author":"JR Carapetis","year":"2014","unstructured":"Carapetis JR, Jacoby P, Carville K et al (2014) Effectiveness of clindamycin and intravenous immunoglobulin, and risk of disease in contacts, in invasive group a streptococcal infections. Clin Infect Dis 59:358\u2013365","journal-title":"Clin Infect Dis"},{"key":"4786_CR14","doi-asserted-by":"crossref","unstructured":"Kadri SS, Swihart BJ, Bonne SL et al (2017) Impact of intravenous immunoglobulin on survival in necrotizing fasciitis with vasopressor-dependent shock: a propensity-score matched analysis from 130 US hospitals. Clin Infect Dis 64:877\u2013885","DOI":"10.1093\/cid\/ciw871"},{"key":"4786_CR15","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1007\/s00134-014-3474-6","volume":"40","author":"I Cavazzuti","year":"2014","unstructured":"Cavazzuti I, Serafini G, Busani S et al (2014) Early therapy with IgM-enriched polyclonal immunoglobulin in patients with septic shock. Intensive Care Med 40:1888\u20131896","journal-title":"Intensive Care Med"},{"key":"4786_CR16","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1056\/NEJMp0911494","volume":"362","author":"E Basch","year":"2010","unstructured":"Basch E (2010) The missing voice of patients in drug-safety reporting. N Engl J Med 362:865\u2013869","journal-title":"N Engl J Med"},{"key":"4786_CR17","first-page":"A5250","volume":"63","author":"MB Madsen","year":"2016","unstructured":"Madsen MB, Lange T, Hjortrup PB, Perner A (2016) Immunoglobulin for necrotising soft tissue infections (INSTINCT): protocol for a randomised trial. Dan Med J 63:A5250","journal-title":"Dan Med J"},{"key":"4786_CR18","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1128\/JCM.33.9.2382-2387.1995","volume":"33","author":"I Brook","year":"1995","unstructured":"Brook I, Frazier EH (1995) Clinical and microbiological features of necrotizing fasciitis. J Clin Microbiol 33:2382\u20132387","journal-title":"J Clin Microbiol"},{"key":"4786_CR19","volume-title":"User\u2019s manual for the SF-36v2 health survey","author":"ME Maurish","year":"2011","unstructured":"Maurish ME (2011) User\u2019s manual for the SF-36v2 health survey, 3rd edn. Quality Metric, Lincoln","edition":"3"},{"key":"4786_CR20","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1365-2044.1997.015-az014.x","volume":"52","author":"PS Chrispin","year":"1997","unstructured":"Chrispin PS, Scotton H, Rogers J et al (1997) Short Form 36 in the intensive care unit: assessment of acceptability, reliability and validity of the questionnaire. Anaesthesia 52:15\u201323","journal-title":"Anaesthesia"},{"key":"4786_CR21","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1097\/00003246-200111000-00012","volume":"29","author":"NA Black","year":"2001","unstructured":"Black NA, Jenkinson C, Hayes JA et al (2001) Review of outcome measures used in adult critical care. Crit Care Med 29:2119\u20132124","journal-title":"Crit Care Med"},{"key":"4786_CR22","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJMoa071366","volume":"358","author":"CL Sprung","year":"2008","unstructured":"Sprung CL, Annane D, Keh D et al (2008) Hydrocortisone therapy for patients with septic shock. N Engl J Med 358:111\u2013124","journal-title":"N Engl J Med"},{"key":"4786_CR23","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1007\/s00134-013-3111-9","volume":"39","author":"N Haase","year":"2013","unstructured":"Haase N, Wetterslev J, Winkel P, Perner A (2013) Bleeding and risk of death with hydroxyethyl starch in severe sepsis: post hoc analyses of a randomized clinical trial. Intensive Care Med 39:2126\u20132134","journal-title":"Intensive Care Med"},{"key":"4786_CR24","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1056\/NEJMoa1204242","volume":"367","author":"A Perner","year":"2012","unstructured":"Perner A, Haase N, Guttormsen AB et al (2012) Hydroxyethyl starch 130\/0.42 versus Ringer\u2019s acetate in severe sepsis. N Engl J Med 367:124\u2013134","journal-title":"N Engl J Med"},{"key":"4786_CR25","doi-asserted-by":"crossref","first-page":"2703","DOI":"10.1001\/jama.2016.7207","volume":"315","author":"K Schmidt","year":"2016","unstructured":"Schmidt K, Worrack S, Von Korff M et al (2016) Effect of a primary care management intervention on mental health-related quality of life among survivors of sepsis: a randomized clinical trial. JAMA 315:2703\u20132711","journal-title":"JAMA"},{"key":"4786_CR26","doi-asserted-by":"crossref","first-page":"e004966","DOI":"10.1136\/bmjopen-2014-004966","volume":"4","author":"JD Paratz","year":"2014","unstructured":"Paratz JD, Kenardy J, Mitchell G et al (2014) IMPOSE (IMProving Outcomes after Sepsis)-the effect of a multidisciplinary follow-up service on health-related quality of life in patients postsepsis syndromes-a double-blinded randomised controlled trial: protocol. BMJ Open 4:e004966","journal-title":"BMJ Open"},{"key":"4786_CR27","doi-asserted-by":"crossref","first-page":"R58","DOI":"10.1186\/cc12586","volume":"17","author":"P Wittbrodt","year":"2013","unstructured":"Wittbrodt P, Haase N, Butowska D et al (2013) Quality of life and pruritus in patients with severe sepsis resuscitated with hydroxyethyl starch long-term follow-up of a randomised trial. Crit Care 17:R58","journal-title":"Crit Care"},{"key":"4786_CR28","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1097\/00005650-200107000-00004","volume":"39","author":"P Diehr","year":"2001","unstructured":"Diehr P, Patrick DL, Spertus J et al (2001) Transforming self-rated health and the SF-36 scales to include death and improve interpretability. Med Care 39:670\u2013680","journal-title":"Med Care"},{"key":"4786_CR29","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1007\/s00134-016-4437-x","volume":"42","author":"SL Ryg\u00e5rd","year":"2016","unstructured":"Ryg\u00e5rd SL, Holst LB, Wetterslev J et al (2016) Long-term outcomes in patients with septic shock transfused at a lower versus a higher haemoglobin threshold: the TRISS randomised, multicentre clinical trial. Intensive Care Med 42:1685\u20131694","journal-title":"Intensive Care Med"},{"key":"4786_CR30","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1136\/bmj.330.7491.594","volume":"330","author":"VM Montori","year":"2005","unstructured":"Montori VM, Permanyer-Miralda G, Ferreira-Gonz\u00e1lez I et al (2005) Validity of composite end points in clinical trials. BMJ 330:594\u2013596","journal-title":"BMJ"},{"key":"4786_CR31","doi-asserted-by":"crossref","first-page":"357ra124","DOI":"10.1126\/scitranslmed.aag1153","volume":"8","author":"BA Diep","year":"2016","unstructured":"Diep BA, Le VTM, Badiou C et al (2016) IVIG-mediated protection against necrotizing pneumonia caused by MRSA. Sci Transl Med 8:357ra124","journal-title":"Sci Transl Med"},{"key":"4786_CR32","unstructured":"ClinicalTrials.gov (2016) Effectiveness of intravenous immunoglobulins (IVIG) in toxic shock syndromes in children. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02899702?term=NCT02899702&rank=1 . Accessed 23 Nov 2016"},{"key":"4786_CR33","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1080\/00365540600836997","volume":"38","author":"G Goscinski","year":"2006","unstructured":"Goscinski G, Tano E, Thulin P et al (2006) Release of SpeA from Streptococcus pyogenes after exposure to penicillin: dependency on dose and inhibition by clindamycin. Scand J Infect Dis 38:983\u2013987","journal-title":"Scand J Infect Dis"},{"key":"4786_CR34","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1007\/s00134-014-3624-x","volume":"41","author":"S Chevret","year":"2015","unstructured":"Chevret S, Seaman S, Resche-Rigon M (2015) Multiple imputation: a mature approach to dealing with missing data. Intensive Care Med 41:348\u2013350","journal-title":"Intensive Care Med"},{"key":"4786_CR35","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","volume":"315","author":"M Singer","year":"2016","unstructured":"Singer M, Deutschman CS, Seymour CW et al (2016) The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA 315:801","journal-title":"JAMA"},{"key":"4786_CR36","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1186\/cc11454","volume":"17","author":"JA Kellum","year":"2013","unstructured":"Kellum JA, Lameire N (2013) Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (Part 1). Crit Care 17:204","journal-title":"Crit Care"}],"container-title":["Intensive Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00134-017-4786-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00134-017-4786-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00134-017-4786-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T22:51:26Z","timestamp":1750200686000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00134-017-4786-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,18]]},"references-count":36,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["4786"],"URL":"https:\/\/doi.org\/10.1007\/s00134-017-4786-0","relation":{},"ISSN":["0342-4642","1432-1238"],"issn-type":[{"value":"0342-4642","type":"print"},{"value":"1432-1238","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,18]]}}}